Categories

Chemistry

3D Printing, Surface technologies and New Materials
- 3D Printing/Lithography Technologies
- Surface Technologies
Agriculture
- Agritec
Bio-based Economy, Food and Personal Care
- Composite Materials & New Materials
- Food, Nutrition & Personal Care
- Industrial Biotech
Digital Chemistry
- R&D Processes & Logistics
- Sensors and Measurement Techniques
- Simulations and Quantum Chemistry
- Sustainability
Energy, Cleantech and Environment
- Energy Generation / Storage
- Recycling
- Water & Mining

Digital Tech

Applications
- 3D-Print
- Blockchain
- e-Commerce
- Health & Lifestyle
- Jobs
- Mobility
- PropTech/ConTech/LegalTech
- Publishing
- Travel
FinTech
Tech/Infrastructure
- AdTech
- AI
- Big Data Analytics
- Business Analytics
- Cloud Infrastructure
- Communication
- Developer Tools
- IT Security
- Marketing
- Productivity-Tools
- Retail Intelligence
- Search
- Social
- Sustainability

Industrial Technology

Access
Applications
- Logistics
- Mobility
- Software
- Virtual and Augmented Reality
Illumination / Projection / Audio
Industrial Software
Metrology
Optical Metrology
Semiconductor
Tech/Infrastructure
- additive Manufacturing
- Energy Generation/Storage
- Energy Management
- Micro Systems Technology
- Production
- Quantum Technology
- Recycling
- Robotics
- Security/Access
- Sensornetworks

Life Sciences

Diagnostic
- Biosensors
- In-Vitro Dx
Digital Health
Green Biotech
Medical Technology
- Aesthetics
- cardiovascular devices
- Emergency Care
- Imaging & Navigation
- Neuromodulation
- New Materials
- Orthopedics/ 3-D-Printing
- Patient Monitoring
- Rehabilitation
Pharmaceuticals
- Animal Health
- Cardiology/Cardiovascular
- Drug Delivery
- Gene Therapy
- Hearing loss
- Immunology
- Infectious Diseases
- Metabolic Diseases
- Oncology
- Pain
- Regulatory
- Rejuvenation
R & D Tools

Rodos BioTarget

Development of novel therapeutic approaches addressing infectious and autoimmune diseases as well as cancers via immune cell-specific targeting.

Management

Dr. Marcus Furch

Dr. Robert Gieseler v. d. Crone

Pressemeldungen

Rodos BioTarget Receives Growth Financing of EUR 2.6 m

Rodos BioTarget GmbH (RBT) is pleased to announce that it has in 2012 successfully realized corporate investment actions in the amount of EUR 2.6 million, with additional option payments attached to its milestones for 2013. Institutional investors participating in this round include the InvestImpuls-Fonds of the…

Read

Rodos BioTarget Receives Start-up Financing by High-Tech Gruenderfonds and hannover innovations fonds

Novel platform technology for Targeted Drug Delivery set to enable successful treatment of various infectious diseases and cancers. Rodos BioTarget GmbH [RBT] successfully closed a start-up financing round with High-Tech Gruenderfonds and hannover innovation fonds [hif]. In order to address various chronic infectious…

Read

Info & Contact

: Marcus Furch

E-mail:: m.furch@biotargeting.eu

Web:: www.biotargeting.eu

Address

Feodor-Lynen-Straße 23
30625 Hannover

In portfolio

29. Dec 2008

Sector

Drug Delivery, Life Sciences, Pharmaceuticals

HTGF Manager

Dr. Caroline Fichtner – Senior Investment Manager

Portfolio